Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Viomycin is a member of the tuberactinomycin family, a group of nonribosomal peptide antibiotics exhibiting anti-tuberculosis activity. The tuberactinomycin family is an essential component in the drug cocktail currently used to fight infections of Mycobacterium tuberculosis. Viomycin was the first member of the tuberactinomycins to be isolated and…
Standards, Biosynthesis & Overview
Explore the main themes, entities and connections around Viomycin. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
biosynthesis synthesis nrps vioa peptide viof vioi viog structure streptomyces member tuberactinomycin family used tuberactinomycins drug gene cyclic one vioj
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Viomycin | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Viomycin | ATC code | None | 1.00 | infobox |
| Viomycin | CAS Number | 32988-50-4 N | 1.00 | infobox |
| Viomycin | CAS Number | 37883-00-4 | 1.00 | infobox |
| Viomycin | ChEBI | CHEBI:15782 Y | 1.00 | infobox |
| Viomycin | ChEMBL | ChEMBL1201221 N | 1.00 | infobox |
| Viomycin | ChEMBL | ChEMBL3989823 | 1.00 | infobox |
| Viomycin | ChemSpider | 2301596 Y | 1.00 | infobox |
| Viomycin | ChemSpider | 4445631 | 1.00 | infobox |
| Viomycin | CompTox Dashboard (EPA) | DTXSID0023741 | 1.00 | infobox |
| Viomycin | Drug class | Aminoglycoside | 1.00 | infobox |
| Viomycin | DrugBank | DB06827 | 1.00 | infobox |
| Viomycin | DrugBank | DBSALT000952 | 1.00 | infobox |
| Viomycin | ECHA InfoCard | 100.046.643 | 1.00 | infobox |
| Viomycin | Formula | C25H43N13O10 | 1.00 | infobox |
| Viomycin | KEGG | D02270 | 1.00 | infobox |
| Viomycin | Legal status | US: ℞-only | 1.00 | infobox |
| Viomycin | Molar mass | 685.700 g·mol−1 | 1.00 | infobox |
| Viomycin | PubChem CID | 3037981 | 1.00 | infobox |
| Viomycin | Routes of administration | Intramuscular injection | 1.00 | infobox |
| Viomycin | UNII | YVU35998K5 | 1.00 | infobox |
| Viomycin | UNII | LKO141R05V | 1.00 | infobox |
| Viomycin | is a | member of the tuberactinomycin family | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.